ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

MOLN Molecular Partners AG

3,87
0,00 (0,00%)
Vor Marktöffnung
Zuletzt aktualisiert: 14:06:42
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Molecular Partners AG MOLN NASDAQ Depository Receipt
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 3,87 14:06:42
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
3,87
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
17.5.202412:25EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
16.5.202422:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16.5.202422:00GLOBEInterim Management Statement Q1 2024 of Molecular Partners:..
29.4.202417:00GLOBEMolecular Partners Announces Publication in Cancer..
19.4.202417:12GLOBELife Science Cares Launches in Switzerland
17.4.202417:12GLOBEMolecular Partners Announces All Board Proposals Approved at..
26.3.202414:26GLOBEMolecular Partners Publishes Invitation to Annual General..
14.3.202421:00GLOBEMolecular Partners Reports Corporate Highlights From Q4 2023..
01.3.202422:00GLOBEMolecular Partners To Hold Conference Call to Discuss Fourth..
08.1.202418:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07.1.202422:00GLOBEMolecular Partners Provides Updates at 42nd Annual J.P...
05.1.202422:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05.1.202422:00GLOBEMolecular Partners and Orano Med Announce Co-Development..
14.12.202307:00GLOBEMolecular Partners to Present at 42nd Annual J.P. Morgan..
10.12.202318:00GLOBEMolecular Partners Presents Positive Initial Data from First..
14.11.202307:00GLOBEMolecular Partners to Present on DARPin Oncology Innovations..
03.11.202317:00GLOBEMolecular Partners Presents Updated Positive Data from..
02.11.202311:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02.11.202307:00GLOBEMolecular Partners to Present Initial Data from Ongoing..
01.11.202307:00GLOBEMolecular Partners to Participate in the TD Cowen 7th Annual..
26.10.202322:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26.10.202322:00GLOBEMolecular Partners Interim Management Statement Q3 2023:..
13.9.202307:00GLOBEMolecular Partners Presents New Data on its Radio DARPin..
24.8.202322:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24.8.202322:00GLOBEMolecular Partners Reports H1 2023 Corporate Highlights and..
28.6.202314:34EDGAR2Form S-8 - Securities to be offered to employees in employee..
27.6.202307:00GLOBEMolecular Partners to Present on its Radio DARPin Therapy..
19.6.202318:00GLOBEMolecular Partners to Present at The TD Cowen..
25.5.202323:01GLOBEMolecular Partners to Present Positive Data from Ongoing..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock